Whole-brain analysis of amyotrophic lateral sclerosis by using echo-planar spectroscopic imaging

Radiology

Volumn 267, Issue 3, 2013, Pages 851-857

  Verma, Gaurav ^a   Woo, John H ^a   Chawla, Sanjeev ^a   Wang, Sumei ^a   Sheriff, Sulaiman ^b   Elman, Lauren B ^a   McCluskey, Leo F ^a   Grossman, Murray ^a   Melhem, Elias R ^a   Maudsley, Andrew A ^b   Poptani, Harish ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATINE; N ACETYLASPARTIC ACID;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN MAPPING; BRAIN METABOLISM; BRAIN RADIOGRAPHY; BRAIN REGION; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CUNEUS; ECHO PLANAR IMAGING; FEMALE; FRONTAL INFERIOR OPERCULUM; FRONTAL OPERCULUM; HESCHL GYRUS; HUMAN; IMAGING SOFTWARE; LINGUAL GYRUS; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OCCIPITAL LOBE; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL; ROLANDIC OPERCULUM; SPECTROMETER; SUPRAMARGINAL GYRUS;

AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; ASPARTIC ACID; BRAIN; BRAIN MAPPING; CHOLINE; CREATINE; ECHO-PLANAR IMAGING; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84878331589     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.13121148     Document Type: Article

References (39)

1. Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med 2001;344(22):1688-1700. (Pubitemid 32479968)
2. Rowland LP. Diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1998;160(Suppl 1):S6-S24. (Pubitemid 28522512)
3. Brownell B, Oppenheimer DR, Hughes JT. The central nervous system in motor neurone disease. J Neurol Neurosurg Psychiatry 1970;33(3):338-357.
4. Geser F, Martinez-Lage M, Robinson J, et al. Clinical and pathological continuum of multisystem TDP-43 proteinopathies. Arch Neurol 2009;66(2):180-189.
5. Graham JM, Papadakis N, Evans J, et al. Diffusion tensor imaging for the assessment of upper motor neuron integrity in ALS. Neurology 2004;63(11):2111-2119. (Pubitemid 39636260)
6. Abrahams S, Goldstein LH, Simmons A, et al. Word retrieval in amyotrophic lateral sclerosis: a functional magnetic resonance imaging study. Brain 2004;127(Pt 7):1507-1517. (Pubitemid 38899404)
7. Kaufmann P, Pullman SL, Shungu DC, et al. Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS). Neurology 2004;62(10):1753-1757. (Pubitemid 38661730)
8. Rule RR, Suhy J, Schuff N, Gelinas DF, Miller RG, Weiner MW. Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study. Amyotroph Lateral Scler Other Motor Neuron Disord 2004;5(3):141-149. (Pubitemid 39406513)
9. Pohl C, Block W, Karitzky J, et al. Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis. Arch Neurol 2001;58(5):729-735. (Pubitemid 32423044)
10. Bradley WG, Bowen BC, Pattany PM, Rotta F. 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis. J Neurol Sci 1999;169(1-2):84-86. (Pubitemid 29502512)
11. Block W, Träber F, Flacke S, Jessen F, Pohl C, Schild H. In-vivo proton MR-spectroscopy of the human brain: assessment of N-acetylaspartate (NAA) reduction as a marker for neurodegeneration. Amino Acids 2002;23(1-3):317-323.
12. Bowen BC, Pattany PM, Bradley WG, et al. MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol 2000;21(4):647-658. (Pubitemid 30210426)
13. Chan S, Shungu DC, Douglas-Akinwande A, Lange DJ, Rowland LP. Motor neuron diseases: comparison of single-voxel proton MR spectroscopy of the motor cortex with MR imaging of the brain. Radiology 1999;212(3):763-769. (Pubitemid 29410981)
14. Schuff N, Rooney WD, Miller R, et al. Reanalysis of multislice (1)H MRSI in amyotrophic lateral sclerosis. Magn Reson Med 2001;45(3):513-516. (Pubitemid 32173280)
15. Brown TR, Kincaid BM, Ugurbil K. NMR chemical shift imaging in three dimensions. Proc Natl Acad Sci U S A 1982;79(11):3523-3526. (Pubitemid 12011397)
16. Pohmann R, von Kienlin M, Haase A. Theoretical evaluation and comparison of fast chemical shift imaging methods. J Magn Reson 1997;129(2):145-160. (Pubitemid 127451427)
17. Ebel A, Soher BJ, Maudsley AA. Assessment of 3D proton MR echo-planar spectroscopic imaging using automated spectral analysis. Magn Reson Med 2001;46(6):1072-1078. (Pubitemid 33104294)
18. Fischer LR, Culver DG, Tennant P, et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol 2004;185(2):232-240. (Pubitemid 38084849)
19. Turner MR, Cagnin A, Turkheimer FE, et al. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis 2004;15(3):601-609. (Pubitemid 38429975)
20. Boillée S, Vande Velde C, Cleveland DW. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 2006;52(1):39-59. (Pubitemid 44466358)
21. 1H MRS of basal ganglia and thalamus in amyotrophic lateral sclerosis. NMR Biomed 2011;24(10):1270-1276.
22. Govind V, Sharma KR, Maudsley AA, Arheart KL, Saigal G, Sheriff S. Comprehensive evaluation of corticospinal tract metabolites in amyotrophic lateral sclerosis using whole-brain 1H MR spectroscopy. PLoS ONE 2012;7(4):e35607 .
23. Sach M, Winkler G, Glauche V, et al. Diffusion tensor MRI of early upper motor neuron involvement in amyotrophic lateral sclerosis. Brain 2004;127(Pt 2):340-350. (Pubitemid 38160319)
24. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 1994;124(Suppl):96-107.
25. Govind V, Gold S, Kaliannan K, et al. Wholebrain proton MR spectroscopic imaging of mild-to-moderate traumatic brain injury and correlation with neuropsychological deficits. J Neurotrauma 2010;27(3):483-496.
26. Maudsley AA, Darkazanli A, Alger JR, et al. Comprehensive processing, display and analysis for in vivo MR spectroscopic imaging. NMR Biomed 2006;19(4):492-503. (Pubitemid 43997768)
27. Provencher SW. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed 2001;14(4):260-264. (Pubitemid 32611437)
28. Friston KJ, Ashburner JT, Kiebel SJ, Nichols TE, Penny WD. Statistical parametric mapping: the analysis of functional brain images. London, England: Academic Press, 2001.
29. Ernst T. Quantification and analysis in MR spectroscopy. In: Gillard J, Waldman A, Barker P, eds. Clinical MR neuroimaging: diffusion, perfusion and spectroscopy. Cambridge, England: Cambridge University Press, 2005; 27-37.
30. Christiansen P, Henriksen O, Stubgaard M, Gideon P, Larsson HB. In vivo quantification of brain metabolites by 1H-MRS using water as an internal standard. Magn Reson Imaging 1993;11(1):107-118.
31. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002;15(1):273-289. (Pubitemid 34852226)
32. Geser F, Brandmeir NJ, Kwong LK, et al. Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Arch Neurol 2008;65(5):636-641. (Pubitemid 351679659)
33. Lowe J. New pathological findings in amyotrophic lateral sclerosis. J Neurol Sci 1994;124(Suppl):38-51.
34. Kalra S, Arnold DL, Cashman NR. Biological markers in the diagnosis and treatment of ALS. J Neurol Sci 1999;165(Suppl 1):S27-S32. (Pubitemid 29339555)
35. Wang S, Poptani H, Woo JH, et al. Amyotrophic lateral sclerosis: diffusion-tensor and chemical shift MR imaging at 3.0 T. Radiology 2006;239(3):831-838. (Pubitemid 43830620)
36. Mitsumoto H, Ulug AM, Pullman SL, et al. Quantitative objective markers for upper and lower motor neuron dysfunction in ALS. Neurology 2007;68(17):1402-1410. (Pubitemid 46659092)
37. Bowser R, Cudkowicz M, Kaddurah-Daouk R. Biomarkers for amyotrophic lateral sclerosis. Expert Rev Mol Diagn 2006;6(3):387-398. (Pubitemid 44174343)
38. Miller BL. A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed 1991;4(2):47-52.
39. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser A Stat Soc 1995;57(1):289-300.